Welcome to LookChem.com Sign In|Join Free
  • or
C32H36FN9O11 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1467575-50-3

Post Buying Request

1467575-50-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1467575-50-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1467575-50-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,6,7,5,7 and 5 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1467575-50:
(9*1)+(8*4)+(7*6)+(6*7)+(5*5)+(4*7)+(3*5)+(2*5)+(1*0)=203
203 % 10 = 3
So 1467575-50-3 is a valid CAS Registry Number.

1467575-50-3Downstream Products

1467575-50-3Relevant academic research and scientific papers

Dual-targeting Janus dendrimer based peptides for bone cancer: Synthesis and preliminary biological evaluation

Jiang, Bo,Zhao, Jing,Li, Yanhua,He, Dongsheng,Pan, Junzhu,Cao, Junhan,Guo, Li

, p. 594 - 601 (2014/01/06)

The development of dual-targeting drug delivery system is helpful to overcome the poor physiochemical properties of chemotherapeutic agents. The RGD sequence has a potential dual-targeting property, with which the chemotherapeutic agents can be delivered to bone tissue and tumor. And the Janus dendrimer which consists of two dendrons with different tasks is useful for improving the effect of polymer on pharmacokinetic properties. In this paper, a Janustype peptide dendrimer which consisted of RGD dimer and 5-FU dimer was synthesized and well characterized by 1H NMR and MS techniques, as well as the other three compounds for contrast. The hydroxyapatite binding assay and drug release study were evaluated. The Janus-type dendrimer with both enhanced targeting property and optimized release property, may reduce the side effects in normal tissues and have potential sustained-release effect. Thus, it may represent a novel opportunity to apply the versatile Janus-type dual-targeting delivery system to applications in bone tumor treatment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1467575-50-3